Institutional Ownership Provectus Biopharmaceuticals, Inc. (PVCT)
This table provides information about the institutional ownership of Provectus Biopharmaceuticals, Inc. (PVCT). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 176,812 shares, which have been reported (via 13F filing form) to have a value of $19,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Home Federal Bank Of Tennessee
|
Jan 24, 2025 Q4 2024 |
100,000
shares
|
$11,000
0.0% of portfolio
|
Q3 2017
New holding
|
|
|
Atlas Wealth LLC
Cincinnati, OH |
Feb 11, 2025 Q4 2024 |
26,620
shares
|
$2,928
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Lbmc Investment Advisors, LLC
|
Jan 16, 2025 Q4 2024 |
20,000
shares
|
$2,200
0.0% of portfolio
|
Q3 2024
Reduced 9.09%
|
|
|
Academy Capital Management Inc
Waco, TX |
Feb 06, 2025 Q4 2024 |
20,000
shares
|
$2,200
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Financial Symmetry Inc
Raleigh, NC |
Feb 04, 2025 Q4 2024 |
10,191
shares
|
$1,121
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Huntington National Bank
Columbus, OH |
Feb 12, 2025 Q4 2024 |
1
shares
|
$0
0.0% of portfolio
|
Q2 2019
New holding
|